Perioperative genitourinary infection associated with sodium-glucose co-transporter 2 inhibitor use
Context: Sodium-glucose co-transporter 2 (SGLT-2) inhibitors are a novel treatment approved for type 2 diabetes mellitus to lower hyperglycemia, systolic blood pressure, and promote weight loss. Commonly reported serious adverse events include increased mycotic urogenital infections, orthostatic hyp...
| Main Authors: | , , , |
|---|---|
| 格式: | Article |
| 語言: | English |
| 出版: |
Greater Baltimore Medical Center
2018-09-01
|
| 叢編: | Journal of Community Hospital Internal Medicine Perspectives |
| 主題: | |
| 在線閱讀: | http://dx.doi.org/10.1080/20009666.2018.1527667 |